HIGH GRADE GLIOMA (III OR IV)
Clinical trials for HIGH GRADE GLIOMA (III OR IV) explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE GLIOMA (III OR IV) trials appear
Sign up with your email to follow new studies for HIGH GRADE GLIOMA (III OR IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for deadly brain cancer? early trial launches
Disease control Not yet recruitingThis early-stage study tests a new drug called FZ-AD005 in about 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to target and attack cancer cells. The main goals are to find a safe dose and see if…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with aggressive brain cancer: targeted drug trial launches
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) who have been newly diagnosed with a fast-growing brain tumor (high-grade glioma or DIPG) that has a specific genetic change. The goal is to see if the drug can help them live longer by targeti…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC